You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Authors' response
  1. Heather Milburn1,
  2. Neil Ashman2,
  3. Peter Davies3 on behalf of the BTS Guidelines Group for TB in Renal Patients
  1. 1Department of Respiratory Medicine, Guy's and St Thomas' NHS Foundation Trust, London, UK
  2. 2Department of Renal Medicine, Barts and the London NHS Trust, London, UK
  3. 3Department of Respiratory Medicine, Liverpool Hospitals Trust, Liverpool, UK
  1. Correspondence to Dr Heather Milburn, Chest Clinic, Guy's Hospital, London SE1 9RT, UK; heather.milburn{at}gstt.nhs.uk

https://doi.org/10.1136/thx.2010.150102

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Dr Connell and colleagues for their interesting letter in response to the 2010 British Thoracic Society guidelines for the management of tuberculosis infection and disease in patients with chronic kidney disease (CKD),1 and for demonstrating their recent experience with both commercially available interferon-γ release assays (IGRA) and the Mantoux tuberculin skin test (TST) in a group of patients with CKD who had been exposed to tuberculosis. This is a welcome addition to the literature which currently remains sparse in this patient group, particularly in the …

    View Full Text

    Footnotes

    • Linked articles 149088.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles